Baxter - 37 Year Stock Price History | BAX

Historical daily share price chart and data for Baxter since 1981 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Baxter as of December 11, 2018 is 66.19.
Baxter Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 70.0733 66.8291 77.8000 61.5600 66.1900 2.92%
2017 57.4364 43.7628 65.5547 43.7628 64.3119 47.29%
2016 42.9734 36.1818 48.2695 33.8358 43.6643 17.58%
2015 36.0043 37.7621 40.7587 31.3156 37.1357 -1.63%
2014 36.6684 34.6448 39.1102 33.3229 37.7518 8.40%
2013 34.1908 32.9443 36.7388 31.7580 34.8251 7.28%
2012 27.8361 23.9536 33.2769 23.5289 32.4622 38.42%
2011 25.4218 23.4061 29.2224 22.4013 23.4512 0.05%
2010 22.7704 26.3258 27.8704 18.4581 23.4385 -11.56%
2009 24.1276 24.3718 26.8723 20.7536 26.5020 11.76%
2008 26.9442 25.1779 31.2271 21.3539 23.7125 -6.24%
2007 23.6965 19.9952 26.6156 19.9221 25.2912 26.79%
2006 17.3941 16.2838 20.1070 15.0485 19.9479 24.81%
2005 15.6034 14.4797 17.1272 13.9569 15.9824 10.63%
2004 12.9502 12.3939 14.4672 11.8147 14.4462 15.22%
2003 10.7227 11.5588 12.7760 7.4775 12.5377 11.14%
2002 17.0503 20.9691 23.5360 9.5644 11.2808 -46.73%
2001 18.9194 17.4968 21.6685 15.9098 21.1784 22.85%
2000 13.8050 11.8204 17.3016 9.9774 17.2392 42.52%
1999 12.4735 11.9558 14.4254 11.1971 12.0957 -0.50%
1998 10.7256 9.2975 12.4302 9.0304 12.1564 29.95%
1997 9.2152 7.3709 10.9164 7.3709 9.3550 25.77%
1996 7.4159 6.8261 8.3790 6.5604 7.4380 8.29%
1995 5.7446 4.4730 6.9705 4.3140 6.8688 51.57%
1994 3.9801 3.7245 4.5318 3.3983 4.5318 21.68%
1993 4.0301 4.6945 4.6945 3.0608 3.7245 -21.89%
1992 5.2294 5.6418 5.7683 4.4993 4.7681 -17.07%
1991 4.8118 3.8683 5.8042 3.6211 5.7496 45.97%
1990 3.4326 3.5117 4.0743 2.8593 3.9390 14.41%
1989 2.9221 2.3652 3.5086 2.3652 3.4429 45.56%
1988 2.7401 3.0639 3.4083 2.1994 2.3652 -20.70%
1987 3.1621 2.4791 3.7995 2.3969 2.9827 18.75%
1986 2.3680 2.0224 2.7557 1.9898 2.5117 22.22%
1985 1.9062 1.7132 2.1685 1.6310 2.0550 19.95%
1984 2.1267 3.0336 3.1967 1.5657 1.7132 -43.53%
1983 3.4906 3.0251 4.0859 2.7883 3.0336 -3.89%
1982 2.5308 2.2344 3.2946 2.0387 3.1563 44.42%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $34.845B $10.561B
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $128.234B 19.17
Abbott Laboratories (ABT) United States $124.559B 25.24
Stryker (SYK) United States $64.068B 24.15
Boston Scientific (BSX) United States $50.024B 25.28
Zimmer Biomet Holdings (ZBH) United States $22.662B 14.70
Smith & Nephew SNATS (SNN) United Kingdom $16.335B 0.00
ResMed (RMD) United States $16.088B 30.68
Perrigo (PRGO) Ireland $7.994B 12.13
Bio-Rad Laboratories (BIO) United States $7.541B 48.22
Canopy Growth (CGC) Canada $7.202B 0.00
Hill-Rom Holdings (HRC) United States $6.313B 19.75
Aurora Cannabis (ACB) Canada $5.710B 30.16
Haemonetics (HAE) United States $5.386B 47.36
Insulet (PODD) United States $4.873B 0.00
ICU Medical (ICUI) United States $4.823B 26.87
Hutchison China MediTech (HCM) China $4.087B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.703B 0.00
Neogen (NEOG) United States $3.227B 48.87
Agios Pharmaceuticals (AGIO) United States $3.067B 0.00
NuVasive (NUVA) United States $2.881B 26.81
National Vision Holdings (EYE) United States $2.462B 47.61
NxStage Medical (NXTM) United States $1.923B 0.00
Quidel (QDEL) United States $1.887B 24.60
Aphria (APHA) $1.401B 0.00
Phibro Animal Health (PAHC) United States $1.335B 18.89
AtriCure (ATRC) United States $1.205B 0.00
Cardiovascular Systems (CSII) United States $1.013B 1457.00
VAREX IMAGING (VREX) United States $0.918B 18.37
PetIQ (PETQ) United States $0.827B 21.44
Meridian Bioscience (VIVO) United States $0.780B 24.85
Surmodics (SRDX) United States $0.773B 117.67
OraSure Technologies (OSUR) United States $0.754B 42.45
Cerus (CERS) United States $0.748B 0.00
Omeros (OMER) United States $0.679B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.663B 21.26
Lantheus Holdings (LNTH) United States $0.647B 20.02
MacroGenics (MGNX) United States $0.568B 0.00
NanoString Technologies (NSTG) United States $0.537B 0.00
LeMaitre Vascular (LMAT) United States $0.510B 25.03
Owens & Minor (OMI) United States $0.454B 5.13
Quanterix (QTRX) United States $0.443B 0.00
TG Therapeutics (TGTX) United States $0.424B 0.00
Insys Therapeutics (INSY) United States $0.382B 0.00
Evolus (EOLS) United States $0.374B 0.00
Utah Medical Products (UTMD) United States $0.340B 21.97
VAPOTHERM INC (VAPO) United States $0.318B 0.00
Cytosorbents (CTSO) United States $0.287B 0.00
Bovie Medical (BVX) United States $0.240B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.234B 0.00
Surface Oncology (SURF) United States $0.231B 0.00
BioLife Solutions (BLFS) United States $0.208B 281.75
Chimerix (CMRX) United States $0.171B 0.00
Rockwell Medical (RMTI) United States $0.171B 0.00
Fonar (FONR) United States $0.134B 6.71
Imprimis Pharmaceuticals (IMMY) United States $0.126B 0.00
Chembio Diagnostics (CEMI) United States $0.106B 0.00
United-Guardian (UG) United States $0.080B 16.66
Female Health (VERU) United States $0.077B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.071B 0.00
InfuSystems Holdings (INFU) United States $0.066B 0.00
Trinity Biotech (TRIB) Ireland $0.063B 17.33
CAS Medical Systems (CASM) United States $0.055B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.045B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Neurotrope (NTRP) United States $0.039B 0.00
Myomo (MYO) United States $0.021B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.018B 0.00
Capricor Therapeutics (CAPR) United States $0.017B 0.00
Akers Biosciences Inc (AKER) United States $0.016B 0.00
Senestech (SNES) United States $0.016B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.006B 0.00